Rankings
▼
Calendar
ARCT Q2 2024 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena
ARCT
Arcturus Therapeutics Holdings Inc.
$217M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$46M
+337.1% YoY
Gross Profit
$46M
100.0% margin
Operating Income
-$21M
-46.0% margin
Net Income
-$17M
-37.4% margin
EPS (Diluted)
$-0.64
QoQ Revenue Growth
+41.0%
Cash Flow
Operating Cash Flow
-$30M
Free Cash Flow
-$30M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$389M
Total Liabilities
$130M
Stockholders' Equity
$259M
Cash & Equivalents
$315M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$46M
$11M
+337.1%
Gross Profit
$46M
$7M
+578.3%
Operating Income
-$21M
-$55M
+61.8%
Net Income
-$17M
-$53M
+67.2%
Revenue Segments
Collaboration Revenue
$46M
92%
Grant
$4M
8%
← FY 2024
All Quarters
Q3 2024 →